Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

AGMBAGMB
1 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in AGOMAB THERAPEUTICS NV

CITADEL ADVISORS LLC holds 35,000 shares of AGMB (AGOMAB THERAPEUTICS NV), worth $367,150 as of 2026-Q1. This is a new position. AGMB represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$367,150

Current Shares

35,000

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
New
35,000
-
$367,1500.0%$10.49
33

Other major holders of AGMB: FEDERATED HERMES, INC., FMR LLC, Aberdeen Group plc, LMR Partners LLP, MILLENNIUM MANAGEMENT LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used